Prognostic significance of metallothionein expression in correlation with Ki-67 expression in adenocarcinomas of large intestine

被引:0
|
作者
Dziegiel, P
Forgacz, J
Suder, E
Surowiak, P
Kornafel, J
Zabel, M
机构
[1] Wroclaw Med Univ, Chair & Dept Histol & Embryol, PL-50368 Wroclaw, Poland
[2] Poznan Med Univ, Chair Histol & Embryol, Poznan, Poland
[3] Wroclaw Med Univ, Dept Gynaecol Oncol, Wroclaw, Poland
[4] Wroclaw Med Univ, Chair Oncol, Wroclaw, Poland
[5] Wroclaw Med Univ, Chair & Dept Anat, Wroclaw, Poland
[6] Lower Silesia Ctr Oncol, Wroclaw, Poland
关键词
metallothionein; Ki-67; large intestine adenocarcinoma;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The study aimed at determining levels of metallothionein (MT) and Ki-67 antigen expression in adenocarcinomas of large intestine and examining relation of the expression levels with various clinical and pathological variables. The studies were performed on 81 cases of large intestine adenocarcinoma. Using immunocytochemistry, expressions of NIT (positive reaction in 73 cases) and of Ki-67 (positive reaction in 79 cases) antigen were examined and the obtained results were compared with, i.a., grade (G) of the tumour and depth to which intestinal wall was infiltrated by individual tumours. Patient survival analysis was also performed, as correlated to expression levels of the two antigens. The obtained results permitted to disclose that the lower was grade of histological differentiation (G2, G3), the more pronounced was expression of NIT and Ki-67. Also, the deeper was neoplastic infiltration of intestinal wall, the more pronounced was MT and Ki-67 expression. Despite the relatively strong correlation between MT expression and Ki-67 expression (r=0.536; p<0.05), only Ki-67 antigen expression in large intestine adenocarcinomas was inversely correlated to survival of the patients. Ki-67 proved to be a better prognostic marker, as compared to MT, in large intestine adenocarcinomas.
引用
收藏
页码:401 / 407
页数:7
相关论文
共 50 条
  • [31] Analysis of Ki-67 expression in oral squamous cell carcinoma: Why Ki-67 is not a prognostic indicator
    Gonzalez-Moles, M. A.
    Ruiz-Avila, I.
    Gil-Montoya, J. A.
    Esteban, F.
    Bravo, M.
    ORAL ONCOLOGY, 2010, 46 (07) : 525 - 530
  • [32] Ki-67 gene expression
    Sigrid Uxa
    Paola Castillo-Binder
    Robin Kohler
    Konstanze Stangner
    Gerd A. Müller
    Kurt Engeland
    Cell Death & Differentiation, 2021, 28 : 3357 - 3370
  • [33] Ki-67 gene expression
    Uxa, Sigrid
    Castillo-Binder, Paola
    Kohler, Robin
    Stangner, Konstanze
    Mueller, Gerd A.
    Engeland, Kurt
    CELL DEATH AND DIFFERENTIATION, 2021, 28 (12): : 3357 - 3370
  • [34] Ki-67 gene expression
    Uxa, Sigrid
    Castillo-Binder, Paola
    Kohler, Robin
    Stangner, Konstanze
    Mueller, Gerd
    Engeland, Kurt
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 176 - 176
  • [35] Clinical Significance of Smac and Ki-67 Expression in Pancreatic Cancer
    Hu, Hai-Yan
    Liu, Hu
    Zhang, Jia-Wei
    Hu, Kai
    Lin, Yu
    HEPATO-GASTROENTEROLOGY, 2012, 59 (120) : 2640 - 2643
  • [36] The role of Ki-67 expression gastric cancer as a prognostic biomarker
    Lee, Won Sup
    CANCER SCIENCE, 2018, 109 : 914 - 914
  • [37] Ki-67 expression as a prognostic marker in patients with hepatocellular carcinoma
    King, KL
    Hwang, JJ
    Chau, GY
    Tsay, SH
    Chi, CW
    Lee, TG
    Wu, LH
    Wu, CW
    Lui, WY
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1998, 13 (03) : 273 - 279
  • [38] Ki-67 expression as a prognostic factor of glioma in Indonesian population
    Dwianingsih, Ery Kus
    Pranacipta, Sofia
    Theresia, Emilia
    Malueka, Rusdy
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [39] Prognostic value of Ki-67 expression in renal cell carcinomas
    Aaltomaa, S
    Lipponen, P
    AlaOpas, M
    Eskelinen, M
    Syrjanen, K
    EUROPEAN UROLOGY, 1997, 31 (03) : 350 - 355
  • [40] Expression of Ki-67 as a prognostic factor in patients with colorectal cancer
    Zhabagin, K. T.
    ANNALS OF ONCOLOGY, 2019, 30